Bridgehead International
  • Home
  • About Us
  • Services
  • Global Reach
  • Clients
  • Articles
  • Meet Us
  • Contact
 

Articles

Please select an article

Effective Due Diligence

Biotech Due Diligence

HPV DNA Co-Testing Adoption and Its Effect on Patient Annual Visits

Spotlight on Germany

Spotlight on the USA

Spotlight on Turkey

IP Due Diligence

Health Economic Impact Study

Pricing and Reimbursement

Strategies for Biogeneric Success

Reference Pricing

IP Valuation

Mergers and Acqusitions

Setting Commmercial Terms

R&D Planning and Prioritisation

  • Effective Due Diligence
  • Biotech Due Diligence
  • HPV DNA Co-Testing Adoption
  • Spotlight on Germany
  • Spotlight on the USA
  • Spotlight on Turkey
  • IP Due Diligence
  • Health Economic Impact Study
  • Pricing and Reimbursement
  • Strategies for Biogeneric Success
  • Reference Pricing
  • IP Valuation
  • Mergers and Acquisitions
  • Setting Commercial Terms
  • R&D Planning and Prioritisation

News

Bridgehead Pharmaceutical and Medical Device Consulting in Japan
Jun 1, 2010

Improved Cervical Cancer Screening Without Reimbursement Challenges
Apr 13, 2010

Personalised Medicine - Bridgehead International Enhances its Services
Jan 20, 2010

Integrating Pharma R&D and Supply Chain Issues with Commerical Strategy
Oct 23, 2009

View All

Copyright © 1998-2010 Bridgehead International Ltd. All Rights Reserved.
Login   |   Privacy Policy   |   Website Design
The Queen's Awards for Enterprise 2007